Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 3
1993 4
1994 5
1995 4
1996 7
1997 5
1998 10
1999 3
2000 10
2001 9
2002 7
2003 7
2004 7
2005 5
2006 3
2007 7
2008 18
2009 9
2010 9
2011 4
2012 10
2013 5
2014 4
2015 4
2016 3
2017 1
2018 7
2019 4
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Results by year
Filters applied: . Clear all
Page 1
White paper on microbial anti-cancer therapy and prevention.
Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G. Forbes NS, et al. Among authors: vile rg. J Immunother Cancer. 2018 Aug 6;6(1):78. doi: 10.1186/s40425-018-0381-3. J Immunother Cancer. 2018. PMID: 30081947 Free PMC article. Review.
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
Driscoll CB, Schuelke MR, Kottke T, Thompson JM, Wongthida P, Tonne JM, Huff AL, Miller A, Shim KG, Molan A, Wetmore C, Selby P, Samson A, Harrington K, Pandha H, Melcher A, Pulido JS, Harris R, Evgin L, Vile RG. Driscoll CB, et al. Among authors: vile rg. Nat Commun. 2020 Feb 7;11(1):790. doi: 10.1038/s41467-020-14568-7. Nat Commun. 2020. PMID: 32034147 Free PMC article.
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.
Jennings VA, Scott GB, Rose AMS, Scott KJ, Migneco G, Keller B, Reilly K, Donnelly O, Peach H, Dewar D, Harrington KJ, Pandha H, Samson A, Vile RG, Melcher AA, Errington-Mais F. Jennings VA, et al. Among authors: vile rg. Mol Ther. 2019 Jun 5;27(6):1139-1152. doi: 10.1016/j.ymthe.2019.04.008. Epub 2019 Apr 14. Mol Ther. 2019. PMID: 31053413 Free PMC article.
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Samson A, Scott KJ, Taggart D, West EJ, Wilson E, Nuovo GJ, Thomson S, Corns R, Mathew RK, Fuller MJ, Kottke TJ, Thompson JM, Ilett EJ, Cockle JV, van Hille P, Sivakumar G, Polson ES, Turnbull SJ, Appleton ES, Migneco G, Rose AS, Coffey MC, Beirne DA, Collinson FJ, Ralph C, Alan Anthoney D, Twelves CJ, Furness AJ, Quezada SA, Wurdak H, Errington-Mais F, Pandha H, Harrington KJ, Selby PJ, Vile RG, Griffin SD, Stead LF, Short SC, Melcher AA. Samson A, et al. Among authors: vile rg. Sci Transl Med. 2018 Jan 3;10(422):eaam7577. doi: 10.1126/scitranslmed.aam7577. Sci Transl Med. 2018. PMID: 29298869 Free PMC article.
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
Crespo-Rodriguez E, Bergerhoff K, Bozhanova G, Foo S, Patin EC, Whittock H, Buus R, Haider S, Muirhead G, Thway K, Newbold K, Coffin RS, Vile RG, Kim D, McLaughlin M, Melcher AA, Harrington KJ, Pedersen M. Crespo-Rodriguez E, et al. Among authors: vile rg. J Immunother Cancer. 2020 Aug;8(2):e000698. doi: 10.1136/jitc-2020-000698. J Immunother Cancer. 2020. PMID: 32759235 Free PMC article.
Gene therapy.
Vile RG. Vile RG. Curr Biol. 1998 Jan 29;8(3):R73-5. doi: 10.1016/s0960-9822(98)70049-1. Curr Biol. 1998. PMID: 9443920 Free article. Review. No abstract available.
Mighty MyD88 in Health and Disease.
Pulido JS, Raja H, Vile RG, Salomao DR, Viswanatha DS. Pulido JS, et al. Among authors: vile rg. Retina. 2016 Mar;36(3):429-31. doi: 10.1097/IAE.0000000000000921. Retina. 2016. PMID: 26655610 No abstract available.
Metastatic malignant melanoma.
Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR; Melanoma Study Group of the Mayo Clinic Cancer Center. Markovic SN, et al. Among authors: vile rg. G Ital Dermatol Venereol. 2009 Feb;144(1):1-26. G Ital Dermatol Venereol. 2009. PMID: 19218908 Review.
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Wongthida P, Schuelke MR, Driscoll CB, Kottke T, Thompson JM, Tonne J, Stone C, Huff AL, Wetmore C, Davies JA, Parker AL, Evgin L, Vile RG. Wongthida P, et al. Among authors: vile rg. Neuro Oncol. 2020 Dec 18;22(12):1757-1770. doi: 10.1093/neuonc/noaa126. Neuro Oncol. 2020. PMID: 32459315 Free PMC article.
176 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page